mTORc2 in Distal Convoluted Tubule and Renal K + Excretion during High Dietary K + Intake.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38788191.
- Also identified by DOI 10.1681/ASN.0000000000000406 and PMC identifier 11387030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
High K stimulates mechanistic target of rapamycin complex 2 (mTORc2) in the distal convoluted tubule (DCT). Inhibition of mTORc2 decreased the basolateral Kir4.1/Kir5.1 and Na-Cl cotransporter in the DCT. Inhibition of mTORc2 of the DCT compromised kidneys' ability to excrete potassium during high K intake. Renal mechanistic target of rapamycin complex 2 (mTORc2) plays a role in regulating renal K<sup>+</sup> excretion (renal-E<sub>K</sub>) and K<sup>+</sup> homeostasis. Inhibition of renal mTORc2 causes hyperkalemia due to suppressing epithelial Na<sup>+</sup> channel and renal outer medullary K+ (Kir1.1) in the collecting duct. We now explore whether mTORc2 of distal convoluted tubules (DCTs) regulates basolateral Kir4.1/Kir5.1, Na-Cl cotransporter (NCC), and renal-E<sub>K</sub>. We used patch-clamp technique to examine basolateral Kir4.1/Kir5.1 in early DCT, immunoblotting, and immunofluorescence to examine NCC expression and <i>in vivo</i> measurement of urinary K<sup>+</sup> excretion to determine baseline renal-E<sub>K</sub> in mice treated with an mTORc2 inhibitor and in DCT-specific rapamycin-insensitive companion of mTOR knockout (DCT-RICTOR-KO) mice. Inhibition of mTORc2 with AZD8055 abolished high-K<sup>+</sup>–induced inhibition of Kir4.1/Kir5.1 in DCT, high potassium–induced depolarization of the DCT membrane, and high potassium–induced suppression of phosphorylated Na-Cl cotransporter (pNCC) expression. AZD8055 stimulated the 40-pS inwardly rectifying K<sup>+</sup> channel (Kir4.1/Kir5.1-heterotetramer) in early DCT in the mice on overnight high potassium intake; this effect was absent in the presence of protein kinase C inhibitors, which also stimulated Kir4.1/Kir5.1. AZD8055 treatment decreased renal-E<sub>K</sub> in animals on overnight high-potassium diet. Deletion of RICTOR in the DCT increased the Kir4.1/Kir5.1-mediated K<sup>+</sup> currents, hyperpolarized the DCT membrane, and increased the expression of pWNK4 and pNCC. Renal-E<sub>K</sub> was lower and plasma K<sup>+</sup> was higher in DCT-RICTOR-KO mice than corresponding control mice. In addition, overnight high-potassium diet did not inhibit Kir4.1/Kir5.1 activity in the DCT and failed to inhibit the expression of pNCC in DCT-RICTOR-KO mice. Overnight high potassium intake stimulated renal-E<sub>K</sub> in control mice, but this effect was attenuated in DCT-RICTOR-KO mice. Thus, overnight high potassium intake induced hyperkalemia in DCT-RICTOR-KO mice but not in control mice. mTORc2 of the DCT inhibits Kir4.1/Kir5.1 activity and NCC expression and stimulates renal-E<sub>K</sub> during high potassium intake.